TherapeuticsMD

TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to help enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. These products target large, underserved, and growing markets in women's healthcare. The company also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD® and BocaGreenMD® brands.
Company Growth (employees)
Type
Public
HQ
Boca Raton, US
Founded
2008
Size (employees)
159 (est)
TherapeuticsMD was founded in 2008 and is headquartered in Boca Raton, US

Key People at TherapeuticsMD

Robert Finizio

Robert Finizio

Chief Executive Officer
Dan Cartwright

Dan Cartwright

Chief Financial Officer
John Milligan

John Milligan

President
Julia Amadio

Julia Amadio

Chief Product Officer
Brian Bernick

Brian Bernick

MD, Chief Medical Officer
Mitchell Krassan

Mitchell Krassan

Chief Strategy Performance Officer

TherapeuticsMD Office Locations

TherapeuticsMD has an office in Boca Raton
Boca Raton, US (HQ)
6800 Broken Sound Pkwy NW

TherapeuticsMD Data and Metrics

TherapeuticsMD Financial Metrics

TherapeuticsMD's revenue was reported to be $4 m in Q1, 2017
USD

Revenue (Q1, 2017)

4 m

Gross profit (Q1, 2017)

3.3 m

Gross profit margin (Q1, 2017), %

83%

Net income (Q1, 2017)

(21.2 m)

EBIT (Q1, 2017)

(21.3 m)

Market capitalization (15-Sep-2017)

1.3 b

Cash (31-Mar-2017)

113.5 m
TherapeuticsMD's current market capitalization is $1.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

8.8 m15 m20.1 m19.4 m

Revenue growth, %

71%34%(4%)

Cost of goods sold

2 m3.7 m4.5 m4.2 m

Gross profit

6.8 m11.4 m15.6 m15.2 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

3.8 m4.2 m4.5 m4.8 m5.2 m4.9 m4.4 m5.5 m4 m

Cost of goods sold

893 k1.1 m1 m1 m1.2 m1.1 m1.1 m1.2 m659.6 k

Gross profit

2.9 m3.1 m3.4 m3.8 m4 m3.8 m3.3 m4.3 m3.3 m

Gross profit Margin, %

76%74%77%79%77%78%74%78%83%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

54.2 m51.4 m64.7 m131.5 m

Inventories

1 m1.2 m690.2 k1.1 m

Current Assets

59.4 m56.2 m70.7 m139.4 m

Total Assets

62 m59.1 m73.7 m142.5 m
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

35.6 m67 m67.2 m81.1 m182.1 m166.5 m147.5 m113.5 m

Inventories

1.5 m1 m1.2 m870.1 k957.4 k883.7 k843.4 k1.3 m

Current Assets

41.8 m72.2 m73 m87.8 m189.8 m174 m156.1 m121.3 m

Total Assets

44.4 m74.6 m75.7 m90.5 m193 m176.6 m158.8 m124.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.4 m)(54.2 m)(85.1 m)(89.9 m)

Depreciation and Amortization

58.1 k52.5 k62.4 k132.5 k

Accounts Receivable

(1.1 m)(458 k)(917.7 k)(4 m)

Inventories

571.6 k(138.5 k)492 k(386.2 k)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(10.9 m)(17.8 m)(20.9 m)(48.1 m)(67.6 m)(20.9 m)(42 m)(67 m)(21.2 m)

Depreciation and Amortization

14.1 k12.7 k13.6 k27.9 k44.4 k19.6 k24.3 k40.5 k49.7 k

Accounts Receivable

(502.8 k)(1.2 m)(1.5 m)(2.3 m)(1.9 m)(4.2 m)580.9 k

Inventories

1.5 m1 m222.9 k(66.6 k)312.1 k(267.3 k)(193.5 k)(153.2 k)(262.3 k)
USDY, 2017

Revenue/Employee

25.1 k

Financial Leverage

1.1 x
Show all financial metrics

TherapeuticsMD Market Value History

Traffic Overview of TherapeuticsMD

TherapeuticsMD Online and Social Media Presence

TherapeuticsMD Company Life and Culture

You may also be interested in